Garry G. Graham

Clearance concepts in pharmacokinetics

Malcolm Rowland, Leslie Z. Benet, Garry G. Graham · Journal of Pharmacokinetics and Biopharmaceutics · 1973 · 761 citations

Therapeutic Drug Monitoring, Pharmacodynamics, Medicine +4

Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin

Wen‐Hung Chung, Wan‐Chun Chang, Sophie L. Stocker et al. · Annals of the Rheumatic Diseases · 2014 · 186 citations

Correction

Richard O. Day, Garry G. Graham · British Journal of Sports Medicine · 2013 · 136 citations · Full text

Pain Medicine, Thromboxane A2, Pharmacotherapy +16

Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis

Garry G. Graham, G. David Champion, Richard O. Day et al. · Clinical Pharmacology & Therapeutics · 1977 · 110 citations

Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function

Janna K. Duong, Shaun S. Kumar, Carl M. J. Kirkpatrick et al. · Clinical Pharmacokinetics · 2013 · 107 citations

Diabetes Management, Healthy Subjects, Insulin Management +8